Arnuity Ellipta 90 mcg

Arnuity Ellipta 90 mcg is a medicine authorised by Swissmedic under authorisation number 65707. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 January 2016 and the authorisation is valid without a time limit. ATC code R03BA09 places the medicine in the group Drugs for obstructive airway diseases.

  • Dispensing category B
  • Authorisation number 65707
  • ATC R03BA09
  • Synthetic medicines
Authorisation data
Authorisation number65707
NameArnuity Ellipta 90 mcg
Full nameArnuity Ellipta 90 mcg, Einzeldosiertes Pulver zur Inhalation
Authorisation holderGlaxoSmithKline AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeR03BA09
First authorisation28 January 2016
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Arnuity Ellipta 90 mcg, Einzeldosiertes Pulver zur InhalationB28 January 2016
2Arnuity Ellipta 182 mcg, Einzeldosiertes Pulver zur InhalationB28 January 2016
3Arnuity Ellipta 46 mcg, Einzeldosiertes Pulver zur InhalationB18 October 2018

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Einzeldose(n)R03BA0903.04.4.B
33 x 30Einzeldose(n)R03BA0903.04.4.B
230Einzeldose(n)R03BA0903.04.4.B
43 x 30Einzeldose(n)R03BA0903.04.4.B
530Einzeldose(n)R03BA0903.04.4.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Arnuity Ellipta 90 mcg authorised in Switzerland?

Yes. Arnuity Ellipta 90 mcg is authorised by Swissmedic under authorisation number 65707, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Arnuity Ellipta 90 mcg have?

Arnuity Ellipta 90 mcg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Arnuity Ellipta 90 mcg?

The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com